{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:59:44Z","timestamp":1777078784894,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0795-5","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T11:14:06Z","timestamp":1524136446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome \u2013 new data and literature review"],"prefix":"10.1186","volume":"13","author":[{"given":"James F. H.","family":"Pittaway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Holder-Espinasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan E.","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Cundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melita D.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"issue":"241","key":"795_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1259\/0007-1285-21-241-42","volume":"21","author":"N Hajdu","year":"1948","unstructured":"Hajdu N, Kauntze R. Cranio-skeletal dysplasia. Br J Radiol. 1948;21(241):42\u20138. \n                    https:\/\/doi.org\/10.1259\/0007-1285-21-241-42\n                    \n                  .","journal-title":"Br J Radiol"},{"key":"795_CR2","first-page":"595","volume":"94","author":"WD Cheney","year":"1965","unstructured":"Cheney WD. Acro-Osteolysis. Am J Roentgenol Radium Therapy Nucl Med. 1965;94:595\u2013607.","journal-title":"Am J Roentgenol Radium Therapy Nucl Med"},{"issue":"1","key":"795_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.mcd.0000228418.74413.52","volume":"16","author":"LM Albano","year":"2007","unstructured":"Albano LM, Bertola DR, Barba MF, Valente M, Robertson SP, Kim CA. Phenotypic overlap in Melnick-needles, serpentine fibula-polycystic kidney and Hajdu-Cheney syndromes: a clinical and molecular study in three patients. Clin Dysmorphol. 2007;16(1):27\u201333. \n                    https:\/\/doi.org\/10.1097\/01.mcd.0000228418.74413.52\n                    \n                  .","journal-title":"Clin Dysmorphol"},{"issue":"4","key":"795_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/1096-8628(20010515)100:4<292::AID-AJMG1308>3.0.CO;2-4","volume":"100","author":"AM Brennan","year":"2001","unstructured":"Brennan AM, Pauli RM. Hajdu--Cheney syndrome: evolution of phenotype and clinical problems. Am J Med Genet. 2001;100(4):292\u2013310.","journal-title":"Am J Med Genet"},{"issue":"3","key":"795_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/1744-9987.12444","volume":"20","author":"N Battelino","year":"2016","unstructured":"Battelino N, Writzl K, Bratanic N, Irving MD, Novljan G. End-stage renal disease in an infant with Hajdu-Cheney syndrome. Ther Apher Dial. 2016;20(3):318\u201321. \n                    https:\/\/doi.org\/10.1111\/1744-9987.12444\n                    \n                  .","journal-title":"Ther Apher Dial"},{"key":"795_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13023-014-0200-y","volume":"9","author":"E Canalis","year":"2014","unstructured":"Canalis E, Zanotti S. Hajdu-Cheney syndrome: a review. Orphanet J Rare Dis. 2014;9:200. \n                    https:\/\/doi.org\/10.1186\/s13023-014-0200-y\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"795_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ng.779","volume":"43","author":"MA Simpson","year":"2011","unstructured":"Simpson MA, Irving MD, Asilmaz E, Gray MJ, Dafou D, Elmslie FV, Mansour S, Holder SE, Brain CE, Burton BK, Kim KH, Pauli RM, Aftimos S, Stewart H, Kim CA, Holder-Espinasse M, Robertson SP, Drake WM, Trembath RC. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet. 2011;43(4):303\u20135. \n                    https:\/\/doi.org\/10.1038\/ng.779\n                    \n                  .","journal-title":"Nat Genet"},{"issue":"3","key":"795_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm1716","volume":"14","author":"MJ Hilton","year":"2008","unstructured":"Hilton MJ, Tu X, Wu X, Bai S, Zhao H, Kobayashi T, Kronenberg HM, Teitelbaum SL, Ross FP, Kopan R, Long F. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med. 2008;14(3):306\u201314. \n                    https:\/\/doi.org\/10.1038\/nm1716\n                    \n                  .","journal-title":"Nat Med"},{"issue":"20","key":"795_CR9","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1128\/MCB.00299-08","volume":"28","author":"H Fukushima","year":"2008","unstructured":"Fukushima H, Nakao A, Okamoto F, Shin M, Kajiya H, Sakano S, Bigas A, Jimi E, Okabe K. The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis. Mol Cell Biol. 2008;28(20):6402\u201312. \n                    https:\/\/doi.org\/10.1128\/MCB.00299-08\n                    \n                  .","journal-title":"Mol Cell Biol"},{"issue":"4 Pt 1","key":"795_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0022-3476(76)80009-1","volume":"88","author":"DM Brown","year":"1976","unstructured":"Brown DM, Bradford DS, Gorlin RJ, Desnick RJ, Langer LO, Jowsey J, Sauk JJ. The acro-osteolysis syndrome: morphologic and biochemical studies. J Pediatr. 1976;88(4 Pt 1):573\u201380.","journal-title":"J Pediatr"},{"issue":"8","key":"795_CR11","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/art.1780290815","volume":"29","author":"J Udell","year":"1986","unstructured":"Udell J, Schumacher HR Jr, Kaplan F, Fallon MD. Idiopathic familial acroosteolysis: histomorphometric study of bone and literature review of the Hajdu-Cheney syndrome. Arthritis Rheum. 1986;29(8):1032\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"795_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1359\/jbmr.2003.18.1.131","volume":"18","author":"WM Drake","year":"2003","unstructured":"Drake WM, Hiorns MP, Kendler DL. Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patients. J Bone Miner Res. 2003;18(1):131\u20133. \n                    https:\/\/doi.org\/10.1359\/jbmr.2003.18.1.131\n                    \n                  .","journal-title":"J Bone Miner Res"},{"issue":"3","key":"795_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3349\/ymj.2011.52.3.543","volume":"52","author":"S Hwang","year":"2011","unstructured":"Hwang S, Shin DY, Moon SH, Lee EJ, Lim SK, Kim OH, Rhee Y. Effect of Zoledronic acid on Acro-Osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome. Yonsei Med J. 2011;52(3):543\u20136. \n                    https:\/\/doi.org\/10.3349\/ymj.2011.52.3.543\n                    \n                  .","journal-title":"Yonsei Med J"},{"issue":"3","key":"795_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00198-007-0461-6","volume":"19","author":"FE McKiernan","year":"2008","unstructured":"McKiernan FE. Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome: 2-year follow-up. Osteoporosis Int. 2008;19(3):379\u201380. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0461-6\n                    \n                  .","journal-title":"Osteoporosis Int"},{"issue":"3","key":"795_CR15","first-page":"283","volume":"37","author":"A Galli-Tsinopoulou","year":"2012","unstructured":"Galli-Tsinopoulou A, Kyrgios I, Giza S, Giannopoulou EZ, Maggana I, Laliotis N. Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. Minerva Endocrinol. 2012;37(3):283\u20139.","journal-title":"Minerva Endocrinol"},{"issue":"4","key":"795_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ng.778","volume":"43","author":"B Isidor","year":"2011","unstructured":"Isidor B, Lindenbaum P, Pichon O, Bezieau S, Dina C, Jacquemont S, Martin-Coignard D, Thauvin-Robinet C, Le Merrer M, Mandel JL, David A, Faivre L, Cormier-Daire V, Redon R, Le Caignec C. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet. 2011;43(4):306\u20138. \n                    https:\/\/doi.org\/10.1038\/ng.778\n                    \n                  .","journal-title":"Nat Genet"},{"issue":"4","key":"795_CR17","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1074\/jbc.M115.685453","volume":"291","author":"E Canalis","year":"2016","unstructured":"Canalis E, Schilling L, Yee SP, Lee SK, Zanotti S. Hajdu Cheney mouse mutants exhibit osteopenia, increased Osteoclastogenesis, and bone resorption. J Biol Chem. 2016;291(4):1538\u201351. \n                    https:\/\/doi.org\/10.1074\/jbc.M115.685453\n                    \n                  .","journal-title":"J Biol Chem"},{"issue":"3","key":"795_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcp.10208","volume":"194","author":"T Iso","year":"2003","unstructured":"Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003;194(3):237\u201355. \n                    https:\/\/doi.org\/10.1002\/jcp.10208\n                    \n                  .","journal-title":"J Cell Physiol"},{"issue":"4","key":"795_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1210\/en.2016-1787","volume":"158","author":"E Canalis","year":"2017","unstructured":"Canalis E, Sanjay A, Yu J, Zanotti S. An antibody to Notch2 reverses the Osteopenic phenotype of Hajdu-Cheney mutant male mice. Endocrinology. 2017;158(4):730\u201342. \n                    https:\/\/doi.org\/10.1210\/en.2016-1787\n                    \n                  .","journal-title":"Endocrinology"},{"key":"795_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2147\/Ott.S33766","volume":"6","author":"R Olsauskas-Kuprys","year":"2013","unstructured":"Olsauskas-Kuprys R, Zlobin A, Osipo C. Gamma secretase inhibitors of Notch signaling. Oncotargets Ther. 2013;6:943\u201355. \n                    https:\/\/doi.org\/10.2147\/Ott.S33766\n                    \n                  .","journal-title":"Oncotargets Ther"}],"updated-by":[{"DOI":"10.1186\/s13023-019-1084-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0795-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T07:13:27Z","timestamp":1557472407000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0795-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0795-5","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13023-019-1084-7","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"After publication of this article [1], it is noticed reference no. 17 was incorrectly provided, details are shown below.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Rhee reports personal fees from Amgen, personal fees from Eli Lilly, outside the submitted work. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"47"}}